CRO News Marvel Biosciences Signs LOI With Novotech CRO for Phase 1 First-in-Human Trial of MB-204 in Australia 8 October 2026
CRO News Quantum BioPharma Signs Phase 2 Study Start-Up Agreement With Thermo Fisher’s PPD CRO for First-in-Class MS Candidate Lucid-MS 7 October 2026
CRO News CellCarta and Imagene AI Expand CRO Collaboration to Validate and Deploy AI-Powered Biomarker and CDx Programs With Leading Pharma Partners 2 October 2026
CRO News Emerald Clinical Trials Appoints Former Novotech COO Michael Stibilj as CEO to Lead Next Phase of Asia-Pacific CRO Growth 1 October 2026
CRO News BioToxTech Targets 200% Growth in U.S. and European Non-Clinical CRO Orders With Bundled Turnkey Package Model 30 September 2026
Ora Clinical Launches Clinical Intelligence Committee to Bring 14 Global Ophthalmology KOLs Into Real-Time CRO Development Decisions 25 September 2026
CRO News Parexel Launches FSP Integrated Solutions to Move Beyond Headcount-Based CRO Outsourcing With AI-Enabled Outcomes Model 24 September 2026
Content NanoImaging Services and Proteos Merge as TrueCourse Biosciences to Meet Demand for Wet-Lab Validation of AI-Designed Drugs 23 September 2026
CRO News WELL Health Launches WELL Research as Integrated CRO, SMO, and Bioanalytical Platform Built on Canada’s Largest Outpatient Network 23 September 2026
CRO News Everest Clinical Research Acquires Firma Clinical Research’s Data Services Unit to Expand Global Biometrics CRO Capabilities 18 September 2026
